High-frequency mutations in KEAP1 have been identified in Chinese patients with lung squamous cell carcinoma, while the somatic nonsynonymous mutation of KEAP1 in patients with lung cancer is likely to promote tumorigenesis via activation of the KEAP1/NRF2 antioxidant stress response pathway (18). The gene discussed is KEAP1; the disease is lung carcinoma.